Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

LambdaMab - HaemaLogiX

Next Previous
Drug Profile

LambdaMab - HaemaLogiX

Alternative Names: IST-1458; LambdaMab; MDX-1458

Latest Information Update: 28 Nov 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Immune System Therapeutics; Medarex
  • Developer HaemaLogiX
  • Class Antineoplastics; Immunotherapies; Monoclonal antibodies
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Amyloid light-chain amyloidosis
  • No development reported Multiple myeloma
  • Discontinued POEMS syndrome

Most Recent Events

  • 28 Nov 2024 No recent reports of development identified for preclinical development in Multiple-myeloma in Australia (Parenteral)
  • 22 Nov 2022 Preclinical development is still ongoing for Multiple myeloma in Australia (Parenteral) (HaemaLogiX pipeline, November 2022)
  • 22 Nov 2022 Discontinued - Preclinical for POEMS syndrome in Australia (Parenteral) (HaemaLogiX pipeline, November 2022)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top